Skip to main content
. Author manuscript; available in PMC: 2017 Feb 1.
Published in final edited form as: Br J Haematol. 2015 Oct 22;172(3):392–400. doi: 10.1111/bjh.13834

Table IV.

Multivariate analysis of covariates for overall survival

Parameter Hazard ratio
(95% confidence interval)
P value
At Complete Remission (N=260)

Age 1.023 (1.011, 1.036) 0.0002
WBC 1.002 (1.000, 1.004) 0.04
Cytogenetics 0.85 (0.57, 1.25) 0.40
MRD at CR 1.4 (0.94, 2.10) 0.1

At 3 Months from Therapy Initiation (N=216)

Age 1.023 (1.010, 1.036) 0.0004
WBC 1.002 (1.000, 1.004) 0.04
Cytogenetics 0.87 (0.59, 1.28) 0.47
MRD at 3 Months 1.96 (0.85, 4.50) 0.12

At 6 Months from Therapy Initiation (N=166)

Age 1.022 (1.010, 1.035) 0.0005
WBC 1.001 (1.000, 1.003) 0.12
Cytogenetics 0.92 (0.63, 1.35) 0.67
MRD at 6 Months 2.68 (0.89, 8.06) 0.08

WBC, white blood cell count; MRD, minimal residual disease; CR, complete remission